Clinical and translational studies of a phase II trial of the novel oral Akt inhibitor perifosine in relapsed or relapsed/refractory Waldenström's macroglobulinemia

Irene M. Ghobrial, Aldo Roccaro, Fangxin Hong, Edie Weller, Nancy Rubin, Renee Leduc, Meghan Rourke, Stacey Chuma, Antonio Sacco, Xiaoying Jia, Feda Azab, Abdel Kareem Azab, Scott Rodig, Diane Warren, Brianna Harris, Lyuba Varticovski, Peter Sportelli, Xavier Leleu, Kenneth C. Anderson, Paul G. Richardson

Research output: Contribution to journal › Article › peer-review

104 Scopus citations

Sort by
Weight
Alphabetically

Clinical and translational studies of a phase II trial of the novel oral Akt inhibitor perifosine in relapsed or relapsed/refractory Waldenström's macroglobulinemia

Fingerprint

Medicine & Life Sciences